Results
Enter location to sort by distance.
Trial
Research Area
Duration
Locations
-
A5426 Improving Physical Ability and Cellular Senescence Elimination in HIV
This clinical trial is a Phase II study designed to test the safety and effectiveness of a combination of dasatinib…
Open and enrolling
HIV comorbidities and complications
The treatment will be given in six cycles over 12 weeks, with participants taking the medication for two days followed by 12 days without treatment. After the 12-week treatment period, participants will be monitored for another 12 weeks to assess the long-term effects.